2,4-Dibromo-5-methylaniline, 95.0%, 250mg

(diazyn-1-ium-1-yl)[2-(2-{3-[(2,5-dioxopyrrolidin-1-yl)oxy]-3-oxopropoxy}ethoxy)ethyl]azanide, 98%, 250mg

Benzyl (3S,4R)-3-methyl-1,6-diazaspiro[3.4]octane-1-carboxylate, 95%, 100mg

4-chloro-2-(1-oxo-1,3,4,6,7,8,9,10-octahydro-2H-cyclohepta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)nicotinaldehyde, 98%, 100mg

Anthracene-9-carboxylic acid, 95.00%, 25g

Methyl 5-bromo-3-(trifluoromethyl)-2-pyridinecarboxylate, 95.0%, 5g

N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea, 98%, 10mg

4-Fluoro-3-nitro-5-(trifluoromethyl)benzoic acid, 98.0%, 100mg

2-Propylpyridine>98.0%(GC)(T)25mL

4-Chlorobenzyl Bromide>98.0%(GC)25g

N-Acétyl-D-mannosamine, min 98%, 5 g, emballage plastique.

5-bromo-3-iodo-6-methylpyridin-2-ol, 95.0%, 100mg

1-Bromo-2-methoxy-5-methyl-3-nitrobenzene, 98%, 100mg